// App-Quantinova.ai

: AmbOx trial: does ambulatory oxygen improve quality of life in patients with fibrotic interstitial lung disease?

Researchers

Presenter

  • Dina Visca

Principal Investigators

  • Vicky Tsipouri

  • Sara Canu

  • Matteo Bonini

  • Matt Pavitt

  • Sharon Fleming

  • Ashi Firouzi

  • Morag Farquhar

  • Elizabeth Leung

  • Charlotte Hogben

  • Angelo De Lauretis

  • Maria Kokosi

  • John Tayu Lee

  • Rosemary Lyne

  • Naomi Rippon

  • Alfredo Chetta

  • Anne Marie Russell

  • Peter Saunders

  • Vasilis Kouranos

  • Giorgios Margaritopoulos

  • Toby M Maher

  • Anna Stockford

  • Timothy Paul Cullinan

  • Nick Hopkins

  • Surinder Birring

  • Athol U Wells

  • Jennifer Whitty

  • Winston Banya

  • Huzaifa Adamali

  • Lisa Spencer

  • Elisabetta Renzoni

  • Piersante Sestini

Medical Centers

  • The Royal Marsden Hospital, London, United Kingdom

  • The University of East Anglia, Norwich, United Kingdom

  • Imperial College, London, United Kingdom

  • Aintree University Hospital, Liverpool, United Kingdom

  • Spire Bristol Hospital, Bristol, United Kingdom

  • Parma University, Parma, Italy

  • Kings College London, London, United Kingdom

  • Siena University, Siena, Italy

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Interstitial lung disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Cross Over

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • NCT02286063

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved